Ameritas Investment Partners’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$91.5K Hold
9,760
﹤0.01% 1815
2025
Q1
$69.4K Hold
9,760
﹤0.01% 1925
2024
Q4
$114K Hold
9,760
﹤0.01% 1686
2024
Q3
$201K Buy
9,760
+627
+7% +$12.9K 0.01% 1322
2024
Q2
$204K Hold
9,133
0.01% 1249
2024
Q1
$251K Hold
9,133
0.01% 1137
2023
Q4
$278K Buy
9,133
+367
+4% +$11.2K 0.01% 1072
2023
Q3
$277K Buy
8,766
+1,480
+20% +$46.8K 0.01% 991
2023
Q2
$297K Buy
7,286
+755
+12% +$30.8K 0.01% 930
2023
Q1
$243K Sell
6,531
-270
-4% -$10.1K 0.01% 984
2022
Q4
$244K Buy
6,801
+889
+15% +$31.9K 0.01% 1021
2022
Q3
$330K Buy
5,912
+256
+5% +$14.3K 0.01% 860
2022
Q2
$292K Buy
5,656
+276
+5% +$14.2K 0.01% 902
2022
Q1
$391K Hold
5,380
0.01% 868
2021
Q4
$636K Hold
5,380
0.02% 752
2021
Q3
$722K Buy
5,380
+371
+7% +$49.8K 0.03% 703
2021
Q2
$811K Buy
5,009
+547
+12% +$88.6K 0.03% 681
2021
Q1
$358K Buy
4,462
+192
+4% +$15.4K 0.01% 887
2020
Q4
$232K Hold
4,270
0.01% 1057
2020
Q3
$85K Buy
4,270
+398
+10% +$7.92K ﹤0.01% 1531
2020
Q2
$81K Buy
3,872
+826
+27% +$17.3K ﹤0.01% 1542
2020
Q1
$37K Hold
3,046
﹤0.01% 1834
2019
Q4
$45K Hold
3,046
﹤0.01% 1984
2019
Q3
$41K Buy
3,046
+465
+18% +$6.26K ﹤0.01% 2002
2019
Q2
$42K Hold
2,581
﹤0.01% 2012
2019
Q1
$44K Hold
2,581
﹤0.01% 1955
2018
Q4
$35K Hold
2,581
﹤0.01% 2010
2018
Q3
$74K Hold
2,581
﹤0.01% 1744
2018
Q2
$71K Buy
2,581
+1,336
+107% +$36.8K ﹤0.01% 1775
2018
Q1
$26K Hold
1,245
﹤0.01% 2288
2017
Q4
$24K Hold
1,245
﹤0.01% 2355
2017
Q3
$26K Hold
1,245
﹤0.01% 2282
2017
Q2
$20K Buy
1,245
+701
+129% +$11.3K ﹤0.01% 2452
2017
Q1
$8K Buy
+544
New +$8K ﹤0.01% 2760